People in the News

Jun 28, 2017

Xavier Reveles

Bioaffinity Technologies announced the addition of Xavier Reveles as director of operations. He will manage the commercialization of Bioaffinity's diagnostic and therapeutic products. Reveles has 25 years of experience as a clinical geneticist and was laboratory director for Oncopath Laboratory-START Cancer Center. 

Jun 27, 2017

Lisa Kerber, Stephen Silvestro, Fernando Schwartz

Prognos named new members to its management team, including Lisa Kerber as chief operating officer, Stephen Silvestro as chief commercial officer, and Fernando Schwartz as chief data scientist. Kerber had several roles at QuintilesIMS, and was most recently the US VP and GM, Real World Evidence. Silvestro was most recently executive VP, head of global sales at Decision Resources Group. Schwartz was previously at LiveIntent, where he was chief data scientist.

Jun 27, 2017

Brian Morra

Brian Morra has been elected executive chairman of Akonni Biosystems' board of directors. In addition to leading the board, Morra will support Akonni Founder and CEO Charles Daitch. He was a senior VP at Pacific-Sierra Research, and was a president at Veridian. 

Jun 22, 2017

David Daly

Foundation Medicine has announced that David Daly intends to resign for personal reasons effective August 11. Daly currently serves as chief commercial officer and general manager of clinical oncology solutions for the company. No replacement has yet been named.

Jun 22, 2017

Mara Aspinall

OraSure Technologies has appointed Mara Aspinall to its board of directors. Aspinall currently serves as the president and CEO of Health Catalysts. She also serves as the executive chairman of GenePeeks. Prior to these positions, Aspinall served as president, CEO and global head of Roche Tissue Diagnostics. She also founded and served as CEO and director of On-Q-ity, served as president of Genzyme Genetics, served as president of the Genzyme Pharmaceuticals.

Jun 21, 2017

Philippe Goix

Avant Diagnostics has appointed Philippe Goix as president and CEO. Goix comes to Avant from Prism Health Diagnostics where he served as president, CEO, and co-founder. Before his time at Prism Health, he consulted for several healthcare companies, and has also served as president and CEO of Singulex, and president and CEO of Guava Technologies, now part of Merck Millipore.

Jun 21, 2017

Peter Meintjes

Omixon has appointed Peter Meintjes as CEO. Meintjes replaces current CEO Tim Hague who will step into a consultancy role and remains a shareholder of the company. Most recently, Meintjes served as chief commercial officer at Omixon. He joined the company in 2014.

Jun 09, 2017

Kevin Weinstein, Frank Cockerill

Analyte Health has appointed Kevin Weinstein as CEO and Frank Cockerill as chief medical officer. Weinstein will also join the company's board of directors. He joins Analyte from Valence Health where served as the chief growth officer. Weinstein has also held various executive positions with ZirMed, Rise Health, and Allscripts. Cockerill will continue to serve on the company's board of directors.

Jun 05, 2017

Karen Koski

Karen Koski was appointed Oxford Immunotec's newly created position of head of strategy and investor relations. She wll join the firm on June 21. Koski was previously a director and senior equity analyst at investment bank BTIG. 

Jun 05, 2017

Joris Veltman

Joris Veltman has taken the position of director of the Institute of Genetic Medicine at Newcastle University in the UK. He previously served as a professor of translational genomics in the department of human genetics at Radboud University Medical Centre in Nijmegen in the Netherlands, with a joint appointment in the department of clinical genetics at Maastricht University Medical Centre.

Jun 01, 2017

Shelly Guyer

Invitae has appointed Shelly Guyer as its CFO, effective June 12. She will also serve as the company's principal financial officer. Invitae's current CFO Lee Bendekgey will fully transition to his new role as COO. Most recently, Guyer served as CFO of Veracyte. 

May 31, 2017

John Sperzel III, Sharon Klugewicz

Chembio Diagnostics CEO John Sperzel III has taken a medical leave of absence, the firm said. No further details were given. In his absence Sharon Klugewicz will be the acting CEO. She is also Chembio's president of the Americas region, and previously was its COO and VP of QA/QC . 

May 23, 2017

Ronald Louks

NantHealth has appointed Ronald Louks its chief operating officer. Louks previously was president of Devices & Emerging Solutions at Blackberry, and before that was CEO of the OpenNMS Group, as well as the chief strategy officer at HTC. 

 

May 22, 2017

Douglas Wurth

Bluejay Diagnostics' board named Douglas Wurth its chairman. Wurth recently retired from JP Morgan Chase after 19 years there. He was CEO of alternative investments for JP Morgan Asset Management. He previously was CEO of JP Morgan's International Private Bank. 
 

 

May 18, 2017

Don Hardison

Biotheranostics has appointed Don Hardison as CEO, succeeding Nicolas Barthelemy. Hardison originally joined Biotheranostics in July 2016 as part of its board of directors. Most recently, he served as president, CEO, and director of Good Start Genetics. He has also served as CEO of Exact Sciences and held senior leadership roles at Laboratory Corporation of America, Quest Diagnostics, and SmithKline Beecham.

May 17, 2017

Cass Grandone

Cass Grandone has joined Theranos as senior vice president of product development. He previously was VP of global infusion systems R&D at Hospira. He also was at Abbott Diagnostics, starting in design and systems engineering, and eventually becoming divisional vice president of core lab assays and systems product development. 

May 17, 2017

Nadia Altomare

Sera Prognostics has appointed Nadia Altomare as chief commercial officer. In this role, she will lead all commercial activities for Sera as the company makes its groundbreaking PreTRM test available to physicians and patients. Altomare has held senior management positions in single and multi-product/service environments spanning from entrepreneurial to Fortune 500 companies. She joins Sera Prognostics from Abcondia where she served as CEO. Prior to that, she served as VP and general manager of the DNA analysis business at Thermo Fisher Scientific, formerly Life Technologies. She has also held leadership roles at PerkinElmer, including the VP and general manager of the cytogenetic DNA testing business and BP of commercial operations.

May 17, 2017

John Marshall

Caris Life Sciences has appointed John Marshall as its chief medical officer. In this role, Marshall will direct the company's oncology research efforts, guide clinical strategies for innovative precision medicine and tumor profiling services, and continue to serve as chairman of the Caris Centers of Excellence for Precision Medicine Network. He currently serves as associate director for clinical care at the Georgetown Lombardi and chief of the division of hematology-oncology at MedStar Georgetown University Hospital. Marshall is also the founding director of Georgetown Lombardi's Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer.

May 16, 2017

Charles Dockendorff

Hologic said today that it has elected Charles Dockendorff to its board of directors and appointed him to its audit and finance committee. Dockendorff has more than 25 years of experience in the global healthcare industry. He was formerly the executive vice president and chief financial officer of Covidien, a public medical device and supplies company acquired by Medtronic in 2015.  

May 11, 2017

Steven Sepulveda

Mesa Biotech has appointed Steven Sepulveda vice president of global business development and channel management. Sepulveda will be responsible for directing and overseeing all aspects of commercial global sales, business development, strategic alliances, and distributor relationship management. He has 26 years of experience in the IVD business with companies such as Quidel, Beckman Coulter, and Sekisui Diagnostics.

May 11, 2017

John Kraeutler

John Kraeutler will retire as CEO from Meridian Bioscience as part of a planned transition as soon as the firm finds his successor. He will remain as executive chairman of Meridian's board of directors and will be available to assist the new CEO during the transition and onboarding phase, the firm said in a statement. Kraeutler joined the company as CEO in 1992.

May 11, 2017

Madhuri Hegde

PerkinElmer has appointed Madhuri Hegde as VP and chief scientific officer for its newly created Laboratory Services group. In this role, Hegde will oversee the laboratory services group to ensure the delivery of innovative solution to clinical and healthcare system customers, the company said. She joins PerkinElmer from Emory Genetics Lab where she served as chief scientific officer and executive director.

May 10, 2017

Herman Verrelst

Biocartis has appointed Herman Verrelst as its new CEO, effective as of August. Herman currently holds the position of VP and general manager of the genomics and clinical applications division of Agilent Technologies. He joined Agilent from Cartagenia, where he served as CEO and founder until it's acquisition by Agilent. He also served as CEO of Medicim, which was acquired by Swiss-based Nobel Biocare, in addition to serving as CEO and founder of DATA4s, which was acquired by Norkom Technologies.

May 10, 2017

Michaela Ott, Michael Ott, Stephen Von Rump, David Patterson

Medite Cancer Diagnostics has accepted the resignation of Micheala and Michael Ott, who served as chief operating officer and managing director respectively. Both Otts will remain on the company's board of directors, however Michael Ott has stepped down as chairman of the board. The company also appointed Stephen Von Rump as chief commercialization and strategy officer and David Patterson as chairman of the company's board of directors.

May 09, 2017

Michael Rodriguez

GenomeDx Biosciences appointed Michael Rodriguez as CFO, effective immediately. He was an advisor and CFO at Crossover Health. Prior to that, he was CFO at Epic Sciences and chief operating officer at Clarient Diagnostic Services. 

Pages